HeartSciences Operating Expenses Growth & History (HSCS)
HeartSciences's operating expenses was $8.4M for fiscal 2026.
View full HeartSciences company overviewHeartSciences annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-04-30 | $8.4M | $60,377 | +0.72% |
| 2025 | 2025-04-30 | $8.4M | $2.0M | +32.24% |
| 2024 | 2024-04-30 | $6.3M | $202,971 | +3.32% |
| 2023 | 2023-04-30 | $6.1M | $1.4M | +29.67% |
| 2022 | 2022-04-30 | $4.7M | — | — |
HeartSciences quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-04-30 | $2.5M | $613,536 | +31.91% |
| Q3 2026 | 2026-01-31 | $1.9M | −$442,532 | −18.66% |
| Q2 2026 | 2025-10-31 | $2.1M | $89,781 | +4.52% |
| Q1 2026 | 2025-07-31 | $1.9M | −$200,408 | −9.66% |
| Q4 2025 | 2025-04-30 | $1.9M | $43,079 | +2.29% |
| Q3 2025 | 2025-01-31 | $2.4M | $835,951 | +54.44% |
| Q2 2025 | 2024-10-31 | $2.0M | $412,710 | +26.25% |
| Q1 2025 | 2024-07-31 | $2.1M | $745,012 | +55.99% |
| Q4 2024 | 2024-04-30 | $1.9M | $281,131 | +17.59% |
| Q3 2024 | 2024-01-31 | $1.5M | $225,028 | +17.17% |
| Q2 2024 | 2023-10-31 | $1.6M | −$202,582 | −11.41% |
| Q1 2024 | 2023-07-31 | $1.3M | −$100,606 | −7.03% |
| Q4 2023 | 2023-04-30 | $1.6M | −$382,020 | −19.29% |
| Q3 2023 | 2023-01-31 | $1.3M | $208,320 | +18.90% |
| Q2 2023 | 2022-10-31 | $1.8M | $818,049 | +85.49% |
| Q1 2023 | 2022-07-31 | $1.4M | $755,087 | +111.67% |
| Q4 2022 | 2022-04-30 | $2.0M | — | — |
| Q3 2022 | 2022-01-31 | $1.1M | — | — |
| Q2 2022 | 2021-10-31 | $956,856 | — | — |
| Q1 2022 | 2021-07-31 | $676,174 | — | — |
HeartSciences operating expenses trends
Between the periods ended 2022-04-30 and 2026-04-30, HeartSciences's operating expenses increased from $4.7M to $8.4M, a change of $3.7M. The latest reported quarter, Q4 2026, shows $2.5M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review HeartSciences source filings ↗